Matthew A. Williams, Eugene V. Ravkov, Michael J. Bevan  Immunity 

Slides:



Advertisements
Similar presentations
마 민 정마 민 정. introduction In vivo 에서 CD4+ T cell memory differentiation 을 study 하기 위해, TCR transgenic T cell 의 adoptive tranfer model 을 이용. ->SMARTA cell.
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 34, Issue 3, Pages (March 2011)
Volume 45, Issue 2, Pages (August 2016)
Volume 45, Issue 5, Pages (November 2016)
Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Volume 18, Issue 5, Pages (May 2003)
Initial T Cell Receptor Transgenic Cell Precursor Frequency Dictates Critical Aspects of the CD8+ T Cell Response to Infection  Vladimir P. Badovinac,
Volume 27, Issue 4, Pages (October 2007)
Volume 40, Issue 6, Pages (June 2014)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 25, Issue 11, Pages (November 2017)
Volume 33, Issue 1, Pages (July 2010)
Volume 45, Issue 2, Pages (August 2016)
Volume 32, Issue 3, Pages (March 2010)
Viral Infection Results in Massive CD8+ T Cell Expansion and Mortality in Vaccinated Perforin-Deficient Mice  Vladimir P Badovinac, Sara E Hamilton, John.
Lung Airway-Surveilling CXCR3hi Memory CD8+ T Cells Are Critical for Protection against Influenza A Virus  Bram Slütter, Lecia L. Pewe, Susan M. Kaech,
Volume 28, Issue 1, Pages (January 2008)
Volume 39, Issue 1, Pages (July 2013)
Volume 11, Issue 6, Pages (June 2012)
Volume 31, Issue 1, Pages (July 2009)
Volume 153, Issue 4, Pages (May 2013)
Protective Capacity of Memory CD8+ T Cells Is Dictated by Antigen Exposure History and Nature of the Infection  Jeffrey C. Nolz, John T. Harty  Immunity 
Volume 34, Issue 5, Pages (May 2011)
Volume 36, Issue 1, Pages (January 2012)
A Two-Step Process for Thymic Regulatory T Cell Development
Volume 29, Issue 1, Pages (July 2008)
Volume 17, Issue 3, Pages (October 2016)
Dynamics of Blood-Borne CD8 Memory T Cell Migration In Vivo
Volume 29, Issue 6, Pages (December 2008)
Volume 28, Issue 5, Pages (May 2008)
Volume 35, Issue 2, Pages (August 2011)
Volume 33, Issue 4, Pages (October 2010)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 34, Issue 1, Pages (January 2011)
Volume 38, Issue 6, Pages (June 2013)
Volume 33, Issue 3, Pages (September 2010)
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 35, Issue 4, Pages (October 2011)
Volume 32, Issue 1, Pages (January 2010)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Eric A Butz, Michael J Bevan  Immunity 
Volume 43, Issue 5, Pages (November 2015)
Volume 39, Issue 1, Pages (July 2013)
Volume 34, Issue 6, Pages (June 2011)
Volume 29, Issue 5, Pages (November 2008)
Volume 41, Issue 1, Pages (July 2014)
Volume 29, Issue 4, Pages (October 2008)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 44, Issue 5, Pages (May 2016)
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Volume 35, Issue 1, Pages (July 2011)
Volume 27, Issue 2, Pages (August 2007)
Susan M. Kaech, Scott Hemby, Ellen Kersh, Rafi Ahmed  Cell 
Volume 32, Issue 1, Pages (January 2010)
Volume 16, Issue 12, Pages (September 2016)
Courtney R. Plumlee, Brian S. Sheridan, Basak B. Cicek, Leo Lefrançois 
Volume 40, Issue 2, Pages (February 2014)
Volume 38, Issue 6, Pages (June 2013)
Volume 35, Issue 4, Pages (October 2011)
Volume 38, Issue 2, Pages (February 2013)
Volume 22, Issue 8, Pages (February 2018)
Volume 35, Issue 4, Pages (October 2011)
Volume 30, Issue 5, Pages (May 2009)
Volume 31, Issue 2, Pages (August 2009)
CD25 surface expression and TCR signal strength predict T helper differentiation and memory potential of early effector T cells in vivo. CD25 surface expression.
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
CD4+ memory T cells derived from either CD25hi or CD25lo effector cells respond robustly to secondary challenge. CD4+ memory T cells derived from either.
CD25 expression predicts effector and memory differentiation.
Volume 8, Issue 2, Pages (August 2010)
Presentation transcript:

Rapid Culling of the CD4+ T Cell Repertoire in the Transition from Effector to Memory  Matthew A. Williams, Eugene V. Ravkov, Michael J. Bevan  Immunity  Volume 28, Issue 4, Pages 533-545 (April 2008) DOI: 10.1016/j.immuni.2008.02.014 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Adoptively Transferred SMARTA Cells Mimic the Endogenous CD4+ T Cell Response to LCMV (A) Thy1.1+CD44lo SMARTA cells (1 × 104) were transferred into B6 hosts (Thy1.2+). Mice were infected with LCMV 1 day later, and the subsequent expansion, contraction, and memory maintenance of SMARTA cells in the spleen were calculated on the basis of expression of Thy1.1. Error bars display the standard error of the mean (SEM) (n = 3–4 per time point), and results are representative of four different experiments. (B) Splenocytes harvested at day 8 or day 300 p.i. were restimulated with GP61–80 peptide for 4 hr in the presence of Brefeldin A. Cells were then stained for intracellular expression of IFNγ, TNFα, and IL-2. We gated on CD4+ Thy1.1+ SMARTA responders and CD4+Thy1.1− endogenous responders from the same animal and assessed their ability to make each cytokine at each time point. Flow plots are representative of effector and memory time points over the course of four time-course experiments. Immunity 2008 28, 533-545DOI: (10.1016/j.immuni.2008.02.014) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 SMARTA Cells Expand but Fail to Gain Full Effector Function and Form Memory after Lm-gp61 Infection (A) Thy1.1+CD44lo SMARTA cells (1 × 104) were transferred into B6 hosts (Thy1.2+). Mice were infected with Lm-gp61 or LCMV 1 day later, and the expansion, contraction, and memory maintenance of SMARTA cells in the spleen were assessed. Representative flow plots display the frequency of Thy1.1+CD4+ SMARTA cells in the spleen at day 8 and day 60 p.i. for each infection. (B) Representative flow plots display the frequency of IFNγ-producing endogenous CD4+ responders (CD4+Thy1.1−) in the spleen after peptide restimulation in the presence of Brefeldin A. (C) Representative flow plots compare the ability of SMARTA cells (CD4+Thy1.1+) and endogenous CD4+ responders (CD4+Thy1.1−) in the spleen to make IFNγ, TNFα, and IL-2 after peptide restimulation at day 8 p.i. Flow plots are representative of six separate experiments. (D) The number of SMARTA (Thy1.1+) and endogenous (IFNγ-producing) responders in the spleen are shown for day 8 and day 60. Error bars represent the SEM (n = 3 per group). Immunity 2008 28, 533-545DOI: (10.1016/j.immuni.2008.02.014) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 After Lm-gp61 Infection, Naive SMARTA Cells Lose Function and Disappear whereas Memory SMARTA Differentiate Normally (A) Thy1.1+CD44lo SMARTA cells (1 × 104) were transferred into B6 hosts (Thy1.2+). Mice were infected with Lm-gp61 1 day later, and SMARTA cells were subsequently tracked in the spleen at several time points p.i. on the basis of Thy1.1 expression (left column). Cytokine production by SMARTA (middle column) and endogenous (right column) CD4+ T cell responders from the same animal was assessed at the indicated points. Flow plots are representative of three mice per time point in this experiment, and similar results were found in three separate experiments. (B) Thy1.1+CD44lo SMARTA cells (1 × 104) were transferred into B6 hosts (Thy1.2+). Mice were infected with LCMV 1 day later and then rechallenged with Lm-gp61 180 days after the primary infection. Representative flow plots display the frequency of SMARTA cells in the spleen at 7 and 42 days after rechallenge (top row). The bottom row displays the ability of SMARTA cells at each time point to produce IFNγ and TNFα in response to ex vivo peptide restimulation. Plots are representative of 3–4 mice per group. Immunity 2008 28, 533-545DOI: (10.1016/j.immuni.2008.02.014) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 SMARTA Cells Fail to Differentiate into Memory after Lm-gp61 Infection Regardless of Naive-Precursor Frequency (A) Thy1.1+CD44lo SMARTA cells (1 × 103, 1 × 104, or 1 × 105) were transferred into B6 hosts (Thy1.2+) that were infected with Lm-gp61 1 day later. Representative flow plots display the frequency of Thy1.1+ SMARTA cells among total CD4+ T cells at days 7 and 50 p.i. for each cell dose. (B) Bar graph displays the number of SMARTA cells harvested at day 7 p.i. after transfer of the indicated number of naive SMARTA cells. (C) Bar graph displays the n-fold expansion of SMARTA cells at each cell dose during the first week p.i. Starting numbers were calculated on the basis of a 10% “take” of transferred cells. Error bars represent the SEM (n = 3 per group). Immunity 2008 28, 533-545DOI: (10.1016/j.immuni.2008.02.014) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 SMARTA Responders Demonstrate Lower Functional Avidity, as Compared to Endogenous CD4+ T Cell Responders to Lm-gp61 in the Same Host (A) B6 mice were infected with either LCMV or Lm-gp61. Eight days later, splenocytes were restimulated over a range of GP61–80 peptide concentrations and stained for expression of IFNγ and TNFα. Representative flow plots are gated on CD4+ T cells and show the frequency of cytokine producers after restimulation at the indicate peptide concentrations. (B) The graph displays the number of endogenous CD4+ T cells in the spleen capable of producing IFNγ in response to decreasing concentrations of peptide. (C) Thy1.1+CD44lo SMARTA cells (1 × 104) were transferred into B6 hosts (Thy1.2+), and mice were infected with LCMV 1 day later. The graph displays the percent maximal endogenous or SMARTA CD4+ T cell response induced by ex vivo peptide restimulation, as measured by the frequency of IFNγ-producing responders at each peptide concentration divided by the frequency of IFNγ-producing responders at the highest peptide concentration (1 × 10−5 M). (D) Thy1.1+CD44lo SMARTA cells (1 × 104) were transferred into B6 hosts (Thy1.2+), and mice were infected with Lm-gp61 1 day later. The graph displays the percent maximal endogenous or SMARTA CD4+ T cell response induced by ex vivo peptide restimulation, as measured by the frequency of IFNγ-producing responders at each peptide concentration divided by the frequency of IFNγ-producing responders at the highest peptide concentration (1 × 10−5 M). The error bars represent the SEM (n = 3 per group). Results are representative of four separate experiments. (E) Thy1.1+CD44lo SMARTA cells (1 × 103) were transferred into B6 hosts (Thy1.2+), and mice were infected with LCMV or Lm-gp61 1 day later. Decreasing concentrations of gp66–77:I-Ab class II tetramer was used to stain SMARTA and endogenous responders at day 8 p.i. The graph displays the number of tetramer-positive endogenous cells detected at each concentration, normalized to staining with the control tetramer hCLIP/I-Ab. (F and G) The graph displays the percentage of tetramer-positive cells as compared to the number of tetramer-positive cells at the highest tetramer concentration after LCMV or Lm-gp61 infection. Error bars represent the SEM (n = 4 per group). Immunity 2008 28, 533-545DOI: (10.1016/j.immuni.2008.02.014) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 6 CD4+ Memory T Cells Skew to Higher Functional Avidity over Time (A) B6 mice were infected with LCMV. At 8 or 30 days p.i., splenocytes were restimulated over a range of GP61–80 peptide concentrations ex vivo and stained for expression of IFNγ and TNFα. The graph displays the percent maximal endogenous CD4+ T cell response induced by ex vivo peptide restimulation, as measured by the frequency of cytokine-producing responders at each peptide concentration divided by the frequency of cytokine-producing responders at the highest peptide concentration (1 × 10−5 M). (B) Similar experiments were performed after Lm-gp61 infection. (C) Similar experiments were performed as in (A), except that 1 × 104 CD44lo SMARTA cells were transferred 1 day prior to LCMV infection and the functional avidity of Thy1.1+ SMARTA cells was assessed. (D and E) Experiments similar to those in (A) and (B) were performed, except that functional avidity was assessed at days 60 and 180 p.i. All error bars represent the SEM (n = 3–4 per group). Immunity 2008 28, 533-545DOI: (10.1016/j.immuni.2008.02.014) Copyright © 2008 Elsevier Inc. Terms and Conditions